Aurora Cannabis (ACB) Other Non Operating Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Other Non Operating Income of $689000.0 for Q1 2026, down 81.8% year-on-year from $3.8 million in Q1 2025, and up 225.05% on a QoQ basis from -$551000.0 in Q4 2025.
Aurora Cannabis (ACB) Other Non Operating Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Non Operating Income for 10 consecutive years, with $689000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Non Operating Income fell 81.8% year-over-year to $689000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 98.99% YoY) and the FY2026 annual result came in at $970360.5, down 92.5% from the prior year.
- Other Non Operating Income climbed to $689000.0 in Q1 2026 per ACB's latest filing, from -$551000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for ACB reached as high as $1.0 billion in Q2 2023 and fell as low as -$551000.0 in Q4 2025.
- A 5-year average of $81.5 million and a median of $2.1 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 117302.7% — and 2025, when it slumped 133.25%.
- Year by year, Other Non Operating Income stood at $5.7 million in 2022, then tumbled by 50.33% to $2.8 million in 2023, then plunged by 41.63% to $1.7 million in 2024, then slumped by 133.25% to -$551000.0 in 2025, then soared by 225.05% to $689000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $689000.0, -$551000.0, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 689,000.00 |
| Dec 31, 2025 | -551,000.00 |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 44,024.46 |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 264.00 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 1.01 Bn |
| Dec 31, 2022 | 5.72 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 861,990.38 |
| Mar 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | -1.87 Mn |
| Sep 30, 2021 | 355,895.37 |
| Jun 30, 2021 | 2.64 Mn |
| Mar 31, 2021 | -5.56 Mn |